|
General Information:
-
6 named species: B. melitensis (sheep and goats, cattle in
mid East), B. suis (swine and reindeer, cattle in FL and Latin
America), B. abortus (cattle, bison, and elk), B. canis
(dogs), B. ovis (sheep and goats), B. neotomae (wood
rats), Marine mammals brucellae
-
B. melitensis discovered by Bruce "Malta fever" 1887; B.
abortus discovered by Bang "Bang’s disease" 1897
Disease in humans:
-
Ranges from complicated, eventually fatal disease (rarely) to
fever of unknown origin; frequently assymptomatic; case fatality of 0 -
1% usually due to myocarditis.
-
Transmission by contact with body fluids of infected animals,
ingestion, aerosol, and (rarely) by tissue transplants or sexual contact
-
Symptoms: fever, chills, night sweats, headache, arthralgia,
arthritis, anorexia, nausea, weight loss, weakness, backache, abortions
(rare)
-
B. melitensisis principle cause of human brucellosis; clinically
most severe; in USA due to ingestion of imported unpasteurized goat
cheese.
-
B. ovis and B. neotomae - no known human disease
Causes for "emergence" of wildlife brucellosis as
disease issue:
-
Currently brucellosis in USA = wildlife brucellosis
-
"Ozark Mountain" emergence
-
Game farming
-
Increased popularity of hunting, viewing, etc.
-
Urban sprawl
-
Expanding range of animals (YNP, feral swine)
-
Global trade
-
Recent discovery (marine mammals)
Current status of domestic animal brucellosis in USA
Brucellosis in feral swine
-
3 million feral swine in at least 24 states
-
B. suis biovars 1 and 3
-
Transmission: venereal, ingestion/contact with infected fetuses,
placentas, fluids
-
Signs/lesions: abortion at any stage of gestation, stillbirths, weak
pigs, sterility, lameness, orchitis, arthritis
-
Seroprevalence: 4% (CA) - 53% (FL); majority of seropositives are
culture positive
-
Human disease: packing plant employees, livestock owners, hunters (3
½ weeks after cleaning wild hog)
-
Spread to other species: cattle, dogs
-
Current control strategies: regulations concerning transport;
prevention of contact between feral and domestic swine
-
Research needs: population control; safe efficacious vaccine and
delivery system
Brucellosis in reindeer and caribou
-
Reindeer: 14 herds on Seward Peninsula totaling 20,000 reindeer
(1997); caribou: several hundred thousand in western arctic herd
-
B. suis biovar 4
-
Transmission: ingestion/contact with infected fetuses, placentas,
fluids; venereal(?)
-
Signs/lesions: abortion, retained placenta, lameness, sterility,
orchitis, epididymitis, seminal vesiculitis, metritis, mastitis,
nephritis, bursitis/synnovitis
-
Seroprevalence: reindeer - cyclic - <1% - >20%; caribou - 1% -
24%
-
Human disease: 5 - 20% are seropositive where caribou is eaten
-
Spread to other species: dogs, foxes, wolves, bears, muskox, moose,
cattle (experimentally)
-
Prevention strategies: 2/3 of AK herds are vaccinated ( killed
vaccine);
-
Research needs: safe efficacious vaccine and delivery system
Brucellosis in Greater Yellowstone Area (GYA) elk
-
120,000 elk in GYA; 25,000 winter on 23 feedgrounds
-
B. abortus biovars 1 and 4
-
Transmission: ingestion/contact with infected fetuses, placentas,
fluids
-
Signs/lesions: abortion, stillbirth, bursitis, arthritis, hygromata
-
Seroprevalence: feedground elk - 24%; nonfeedground elk - <2%
-
Human disease: rare
-
Spread to other species: bison, cattle, horses, bears, moose(?),
canids(?)
-
Prevention strategies: ballistic vaccination with Strain 19, habitat
improvement
-
Research needs: safe efficacious vaccine and delivery system;
RB51(?), oral vaccination(?); habitat management strategies
Brucellosis in GYA bison
-
3300 bison in YNP and GTNP
-
B. abortus biovars 1 and 2
-
Transmission: ingestion/contact with infected fetuses, placentas,
fluids; milk; venereal(?)
-
Signs/lesions: third trimester abortion, stillbirth, weak calves,
retained placentas, arthritis, bursitis, hygromata, orchitis,
epididymitis, seminal vesiculitis, metritis
-
Seroprevalence: 50% (YNP); 70% (GTNP); 46% of seropositives are
culture positive
-
Human disease (?)
-
Spread to other species: cattle, elk, bears, canids, moose(?)
-
Prevention strategies: historically - strain 19 vaccination and test
and slaughter
-
Reseach needs: RB51 efficacy studies; adult vaccine safety studies;
nontarget studies; delivery systems; studues related to management
plan
Brucellosis in marine mammals
(?), B. delphini(?); lumpers vs splitters;
probably several species
Transmission: ?, fecal shedding
Signs/lesions: abortion with placentitis (bottlenose dolphin),
subcutaneous lesions (harbor porpoise, common dolphin, striped dolphin)
Seroprevalence: ringed seal (4 - 40%); Atlantic walrus (12%); grey
seal (23%); harbor seal (32%); harbor porpoise (22%); common dolphin (1
of 1); striped dolphin; bottlenose dolphin; killer whale; pilot whale;
hooded seal (35%); harp seal (2%); minke whale (8%); fin whale (11%);
sei whale (14%); California sea lion 5 of 89 (5.6%)
Culture positive: harbor seal, harbor porpoise, common dolphin,
bottlenose dolphin, hooded seal, grey seal, Atlantic white-sided
dolphin, European otter, minke whale
Human disease: ? (1 case in laboratory worker)
Spread to other species: ? (cattle-experimental inoculation caused
seroconversion and abortion)
Prevention strategies: ?
Emerging disease: earliest report was in 1994
Research needs: surveillance, pathogenesis and epidemiology.
General references:
-
Corbel MJ. 1997. Brucellosis: an overview. Emerging Infectious
Diseases 3: 213-230.
-
Moore CG, Schnurrenberger PR. 1981. A review of naturally occurring Brucella
abortus infections in wild mammals. J Am Vet Med Assoc 179:
1105-1112.
-
Davis DS. 1990. Brucellosis in wildlife. In: Nielsen K,
Duncan JR eds. Animal Brucellosis. CRC Press. Boca Raton, FL. pp.
322-334.
-
Rhyan JC. 2000. Brucellosis in terrestrial wildlife and marine
mammals. In: Brown C, Bolin C eds. Emerging Diseases of Animals. ASM
Press. Washington, D.C. pp.161-184.
|